EP
TARO

Eversept Partners’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Eversept Partners’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-263,541
Closed -$11.2M – 85
2024
Q1 		$11.2M Buy
263,541
+7,553
+3% +$318K 0.74% 25
2023
Q4 		$10.7M Buy
255,988
+665
+0.3% +$24.5K 0.94% 24
2023
Q3 		$9.63M Buy
255,323
+5,037
+2% +$189K 0.81% 25
2023
Q2 		$9.49M Buy
250,286
+5,019
+2% +$158K 0.79% 29
2023
Q1 		$5.96M Buy
245,267
+19,805
+9% +$578K 0.42% 40
2022
Q4 		$6.55M Buy
225,462
+2,079
+0.9% +$61.7K 0.57% 36
2022
Q3 		$6.7M Buy
223,383
+2,993
+1% +$103K 0.58% 34
2022
Q2 		$7.97M Buy
220,390
+104
+0% +$3.96K 0.57% 40
2022
Q1 		$9.53M Buy
220,286
+39,135
+22% +$1.83M 0.73% 38
2021
Q4 		$9.08M Buy
181,151
+1,785
+1% +$100K 0.58% 45
2021
Q3 		$11.4M Buy
179,366
+5,117
+3% +$354K 0.79% 36
2021
Q2 		$12.5M Buy
174,249
+9,871
+6% +$725K 0.84% 33
2021
Q1 		$12.1M Buy
164,378
+12,122
+8% +$920K 0.91% 31
2020
Q4 		$11.2M Buy
152,256
+10,367
+7% +$666K 1.31% 23
2020
Q3 		$7.78M Buy
141,889
+36,720
+35% +$2.29M 1.73% 18
2020
Q2 		$6.99M Buy
105,169
+28,710
+38% +$1.93M 0.96% 26
2020
Q1 		$4.68M Buy
76,459
+71,506
+1,444% +$5.3M 1.16% 19
2019
Q4 		$436K Buy
+4,953
New +$418K 0.08% 69

Other funds holding TARO

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $3.3B AUM 20.27% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
LI
LRI Investments Palm Beach Gardens, Florida $1.24B AUM 11.13% 1-Year Est. Return
GCM
Gladius Capital Management Chicago, Illinois $2.24B AUM 23.45% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Eversept Partners's TARO Position: Q2 2024 in Review

Eversept Partners sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2024, closing a stake of 263,541 shares — an estimated $11.2M sold.

Eversept Partners first reported a position in TARO in Q4 2019 and held it in 18 quarters. The position peaked at $12.5M in Q2 2021. 16 funds tracked by Wall St. Rank hold TARO as of Q2 2024.

  • Eversept Partners reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2024 after selling out during the quarter.
  • Eversept Partners sold 263,541 Taro Pharmaceutical Industries Ltd. shares in Q2 2024, an estimated $11.2M.
  • Eversept Partners first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2019 and held it in 18 quarters.
  • Eversept Partners's Taro Pharmaceutical Industries Ltd. position peaked at $12.5M in Q2 2021.
  • 16 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2024.

Based on Eversept Partners's 13F filing for Q2 2024, filed 14 Aug 2024.